NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines Article Report uri icon


MeSH Major

  • Cancer Vaccines
  • Fusion Proteins, bcr-abl
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive


  • The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population.


publication date

  • December 2016



  • Report


PubMed ID

  • 27956535

Additional Document Info

start page

  • 1505

end page

  • 1512


  • 14


  • 12